| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |